Pfizer Inc. (PFE) Net margin 2016–2025
Pfizer Inc. (PFE) net profit margin by fiscal year — reported net income divided by reported revenue.
12.4%FY2025 · since FY2016: 13.7% → 12.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 12.4% | -0.2 pp |
| FY2024 | 12.6% | +8.5 pp |
| FY2023 | 4.2% | -30.0 pp |
| FY2022 | 34.2% | +4.3 pp |
| FY2021 | 29.8% | +7.9 pp |
| FY2020 | 22.0% | -17.2 pp |
| FY2019 | 39.2% | +11.9 pp |
| FY2018 | 27.3% | -13.2 pp |
| FY2017 | 40.6% | +26.9 pp |
| FY2016 | 13.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice